Search

Your search keyword '"Tokgozoglu, L"' showing total 652 results

Search Constraints

Start Over You searched for: Author "Tokgozoglu, L" Remove constraint Author: "Tokgozoglu, L"
652 results on '"Tokgozoglu, L"'

Search Results

2. Impact of diabetes on the management and outcomes in atrial fibrillation: an analysis from the ESC-EHRA EORP-AF Long-Term General Registry

3. Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EORP atrial fibrillation general long-term registry

6. Results from the nationwide French lipids (Lipids Prevention in Daily Practice Survey): Current approaches in secondary and primary prevention by cardiologists

7. Eligibility of icosapent ethyl (EPA) in a French population of coronary outpatients with type 2 diabetes

8. Clinical characteristics of adult and paediatric patients with familial hypercholesterolemia: A real-life cross-sectional study from the Turkish national database

9. Results from the nationwide French glucose (GLP1RA and SGLT2I use by cardiologists survey)

12. Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry

13. Impact of renal impairment on atrial fibrillation

14. Epidemiology and impact of frailty in patients with atrial fibrillation in Europe

17. Impact of diabetes on the management and outcomes in atrial fibrillation: an analysis from the ESC-EHRA EORP-AF Long-Term General Registry

18. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

19. Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation:a report from ESC-EHRA EORP-AF Long-Term General Registry

22. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

23. ESC 2021 Guideline on the prevention of cardiovascular disease in clinical practice clinical practice

24. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

25. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

26. Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry

31. Obesity and cardiovascular risk: a call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: part B: obesity-induced cardiovascular disease, early prevention strategies and future research directions

32. Obesity and cardiovascular risk: A call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: Part A: Mechanisms of obesity induced hypertension, diabetes and dyslipidemia and practice guidelines for treatment

33. 2019 ESC/EAS Guidelines for the management of dyslipidaemias

34. Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia: A Global Call to Action

35. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)

36. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

41. Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry

42. Atherosclerosis

43. Snapshot evaluation of heart failure in Turkey: Baseline characteristics of SELFIE-TR [Türkiye'de kalp yetersizliginin anlik görüntüsü: SELFIE-TR bazal karakteristik özellikleri]

46. Obesity and cardiovascular risk: A call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: Part A: Mechanisms of obesity induced hypertension, diabetes and dyslipidemia and practice guidelines for treatment

47. Obesity and cardiovascular risk: A call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: Part B: Obesity-induced cardiovascular disease, early prevention strategies and future research directions

Catalog

Books, media, physical & digital resources